Column Group II GP, LP's Net Worth
$65.3 Million
Who is Column Group II GP, LP?
Column Group II GP, LP has an estimated net worth of $65.3 Million. This is based on reported shares across multiple companies, which include IMMUNE DESIGN CORP., NGM BIOPHARMACEUTICALS INC, Gritstone Oncology, Inc., RAPT Therapeutics, Inc., Nurix Therapeutics, Inc., Arcus Biosciences, Inc., Oric Pharmaceuticals, Inc., and eFFECTOR Therapeutics, Inc..
SEC CIK
Column Group II GP, LP's CIK is 0001645333
Past Insider Trading and Trends
2022 was Column Group II GP, LP's most active year for acquiring shares with 60 total transactions. Column Group II GP, LP's most active month to acquire stocks was the month of April. 2021 was Column Group II GP, LP's most active year for disposing of shares, totalling 60 transactions. Column Group II GP, LP's most active month to dispose stocks was the month of August. 2019 saw Column Group II GP, LP paying a total of $50,465,991.21 for 22,735,023 shares, this is the most they've acquired in one year. In 2019 Column Group II GP, LP cashed out on 69,442,142 shares for a total of $38,861,210.70, their largest year based on trade value.
Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!
IMMUNE DESIGN CORP. No price found
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| -100.00% | -6.64M |
$5.85 | -$38,861,210.70 |
0
|
Apr 2
| |||
Form 4
| +67.67% | 2.68M |
$4.10 | $10,992,100.00 | 6.64M |
Oct 27
| |||
Form 4
| +25.30% | 800K |
$6.25 | $5,000,000.00 | 3.96M |
Sep 20
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
Gritstone Oncology, Inc. (GRTS) Snapshot price: $2.32
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
|
∞
| 3.1M |
—
|
—
| 3.1M |
Oct 2
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
Nurix Therapeutics, Inc. (NRIX) Snapshot price: $8.31
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| -43.68% | -2.68M |
—
|
—
| 3.45M |
May 5
| |||
Form 4
| +8,007.09% | 6.67M |
—
|
—
| 6.76M |
Jul 28
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
Arcus Biosciences, Inc. (RCUS) Snapshot price: $14.82
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
|
∞
| 3.54M |
—
|
—
| 3.54M |
Mar 19
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
Oric Pharmaceuticals, Inc. (ORIC) Snapshot price: $12.64
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| -21.11% | -1.01M |
$16.00 | $266,000.00 | 3.77M |
Nov 12 - Nov 16
| |||
Form 4
| +6,257.57% | 4.69M |
—
|
—
| 4.77M |
Apr 28
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||